Opinion

Video

Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer

This segment delves into targeting the androgen receptor pathway and conquering treatment resistance for potential breakthroughs in managing advanced prostate cancer

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      An Overview Of Pembrolizumab for High-Risk BCG Unresponsive NMIBC
      An Overview Of Pembrolizumab for High-Risk BCG Unresponsive NMIBC
      1 expert is featured in this series.
      Case 2: A 63-Year-Old Man With Recurrent HSPC
      1 expert is featured in this series.
      Comorbidities and Adherence: Tailoring mHSPC Treatment
      FDA-Approved Options for High-Risk BCG-Unresponsive NMIBC
      FDA-Approved Options for High-Risk BCG-Unresponsive NMIBC
      1 expert in this video
      Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
      2 experts are featured in this series.
      Treatment or Lack of Treatment of Small Renal Masses
      1 expert is featured in this series.
      The current treatment landscape of mHSPC
      2 experts are featured in this series.
      Strengths and Weaknesses of Imaging Modalities in ccRCC
      1 expert in this video
      BPH: Strategies for Guiding Patients From Medication to Intervention
      1 expert is featured in this series.
      Representation of Black men with mHSPC in clinical trials
      Related Content
      Skyler Howell, MD | Credit: X.com
      April 28th 2025

      AUA 2025: GLP-1 RAs could improve sperm count in overweight men

      Patrick Campbell
      New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.
      Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
      May 17th 2025

      Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

      Amy M. Pearlman, MD Alex Tatem, MD
      Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
      Pablo Suarez, MS-4 | Credit: UCSF
      April 26th 2025

      Drinking water contaminants could increase risk of kidney stones, study finds

      Patrick Campbell
      New research links higher drinking water contaminants to increased kidney stone risk.
      Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
      May 4th 2025

      Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

      Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
      Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
      Stacy Loeb, MD, MSc, PhD | Credit: NYU Langone Health
      April 26th 2025

      TikTok, social media does more harm than good for prostate cancer education

      Patrick Campbell
      Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.
      US FDA logo in white over a blue background. | Credit: US Food and Drug Administration
      February 4th 2025

      FDA Updates in Urology: January 2025

      Patrick Campbell
      A recap of the FDA submissions and regulatory decisions in urology from January 2025.
      © 2025 MJH Life Sciences

      All rights reserved.